vs
Niagen Bioscience, Inc.（NAGE）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
READING INTERNATIONAL INC的季度营收约是Niagen Bioscience, Inc.的1.5倍（$50.3M vs $33.8M），Niagen Bioscience, Inc.净利率更高（12.2% vs -5.1%，领先17.3%），Niagen Bioscience, Inc.同比增速更快（16.2% vs -14.2%），过去两年Niagen Bioscience, Inc.的营收复合增速更高（23.6% vs 5.6%）
Niagen Bioscience（原名为ChromaDex）是一家成立于1999年，总部位于加利福尼亚州洛杉矶的生物科技公司。公司业务涵盖标准品、膳食补充剂以及原料技术开发多个领域，目前在纳斯达克挂牌上市。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
NAGE vs RDI — 直观对比
营收规模更大
RDI
是对方的1.5倍
$33.8M
营收增速更快
NAGE
高出30.4%
-14.2%
净利率更高
NAGE
高出17.3%
-5.1%
两年增速更快
NAGE
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $33.8M | $50.3M |
| 净利润 | $4.1M | $-2.6M |
| 毛利率 | 64.1% | — |
| 营业利润率 | 12.1% | -1.9% |
| 净利率 | 12.2% | -5.1% |
| 营收同比 | 16.2% | -14.2% |
| 净利润同比 | -42.4% | -14.5% |
| 每股收益（稀释后） | $0.05 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NAGERDI
| Q4 25 | $33.8M | $50.3M | ||
| Q3 25 | $34.0M | $52.2M | ||
| Q2 25 | $31.1M | $60.4M | ||
| Q1 25 | $30.5M | $40.2M | ||
| Q4 24 | $29.1M | $58.6M | ||
| Q3 24 | $25.6M | $60.1M | ||
| Q2 24 | $22.7M | $46.8M | ||
| Q1 24 | $22.2M | $45.1M |
净利润NAGERDI
| Q4 25 | $4.1M | $-2.6M | ||
| Q3 25 | $4.6M | $-4.2M | ||
| Q2 25 | $3.6M | $-2.7M | ||
| Q1 25 | $5.1M | $-4.8M | ||
| Q4 24 | $7.2M | $-2.2M | ||
| Q3 24 | $1.9M | $-7.0M | ||
| Q2 24 | $-15.0K | $-12.8M | ||
| Q1 24 | $-492.0K | $-13.2M |
毛利率NAGERDI
| Q4 25 | 64.1% | — | ||
| Q3 25 | 64.5% | — | ||
| Q2 25 | 65.0% | — | ||
| Q1 25 | 63.4% | — | ||
| Q4 24 | 62.5% | — | ||
| Q3 24 | 63.5% | — | ||
| Q2 24 | 60.2% | — | ||
| Q1 24 | 60.7% | — |
营业利润率NAGERDI
| Q4 25 | 12.1% | -1.9% | ||
| Q3 25 | 12.5% | -0.6% | ||
| Q2 25 | 10.2% | 4.8% | ||
| Q1 25 | 15.7% | -17.2% | ||
| Q4 24 | 24.4% | 2.6% | ||
| Q3 24 | 6.3% | -0.6% | ||
| Q2 24 | -1.1% | -16.4% | ||
| Q1 24 | -3.3% | -16.7% |
净利率NAGERDI
| Q4 25 | 12.2% | -5.1% | ||
| Q3 25 | 13.5% | -8.0% | ||
| Q2 25 | 11.6% | -4.4% | ||
| Q1 25 | 16.6% | -11.8% | ||
| Q4 24 | 24.6% | -3.8% | ||
| Q3 24 | 7.3% | -11.7% | ||
| Q2 24 | -0.1% | -27.4% | ||
| Q1 24 | -2.2% | -29.4% |
每股收益（稀释后）NAGERDI
| Q4 25 | $0.05 | $-0.11 | ||
| Q3 25 | $0.05 | $-0.18 | ||
| Q2 25 | $0.04 | $-0.12 | ||
| Q1 25 | $0.06 | $-0.21 | ||
| Q4 24 | $0.10 | $-0.11 | ||
| Q3 24 | $0.02 | $-0.31 | ||
| Q2 24 | $0.00 | $-0.57 | ||
| Q1 24 | $-0.01 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $10.5M |
| 总债务越低越好 | — | $185.1M |
| 股东权益账面价值 | $76.5M | $-18.2M |
| 总资产 | $106.4M | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NAGERDI
| Q4 25 | — | $10.5M | ||
| Q3 25 | $64.1M | $8.1M | ||
| Q2 25 | $60.3M | $9.1M | ||
| Q1 25 | $55.5M | $5.9M | ||
| Q4 24 | $44.5M | $12.4M | ||
| Q3 24 | $32.2M | $10.1M | ||
| Q2 24 | $27.7M | $9.3M | ||
| Q1 24 | $27.4M | $7.5M |
总债务NAGERDI
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益NAGERDI
| Q4 25 | $76.5M | $-18.2M | ||
| Q3 25 | $70.7M | $-12.1M | ||
| Q2 25 | $64.2M | $-7.7M | ||
| Q1 25 | $55.3M | $-8.1M | ||
| Q4 24 | $46.1M | $-4.4M | ||
| Q3 24 | $34.4M | $1.6M | ||
| Q2 24 | $30.7M | $6.5M | ||
| Q1 24 | $29.0M | $18.0M |
总资产NAGERDI
| Q4 25 | $106.4M | $434.9M | ||
| Q3 25 | $98.1M | $435.2M | ||
| Q2 25 | $91.5M | $438.1M | ||
| Q1 25 | $81.3M | $441.0M | ||
| Q4 24 | $68.3M | $471.0M | ||
| Q3 24 | $56.5M | $495.7M | ||
| Q2 24 | $54.0M | $494.9M | ||
| Q1 24 | $54.1M | $494.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $679.0K | $4.3M |
| 自由现金流经营现金流 - 资本支出 | — | $4.1M |
| 自由现金流率自由现金流/营收 | — | 8.2% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | 0.16× | — |
| 过去12个月自由现金流最近4个季度 | — | $-2.9M |
8季度趋势，按日历期对齐
经营现金流NAGERDI
| Q4 25 | $679.0K | $4.3M | ||
| Q3 25 | $3.7M | $295.0K | ||
| Q2 25 | $1.3M | $1.6M | ||
| Q1 25 | $7.9M | $-7.7M | ||
| Q4 24 | $8.6M | $8.0M | ||
| Q3 24 | $3.5M | $1.3M | ||
| Q2 24 | $-264.0K | $-10.4M | ||
| Q1 24 | $295.0K | $-2.8M |
自由现金流NAGERDI
| Q4 25 | — | $4.1M | ||
| Q3 25 | — | $-246.0K | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $-8.0M | ||
| Q4 24 | — | $7.0M | ||
| Q3 24 | — | $-1.1M | ||
| Q2 24 | — | $-10.6M | ||
| Q1 24 | — | $-4.7M |
自由现金流率NAGERDI
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | -0.5% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | -19.8% | ||
| Q4 24 | — | 12.0% | ||
| Q3 24 | — | -1.8% | ||
| Q2 24 | — | -22.7% | ||
| Q1 24 | — | -10.4% |
资本支出强度NAGERDI
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 4.3% |
现金转化率NAGERDI
| Q4 25 | 0.16× | — | ||
| Q3 25 | 0.81× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 1.56× | — | ||
| Q4 24 | 1.20× | — | ||
| Q3 24 | 1.86× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NAGE
| TRUNIAGEN Consumer Product | $27.5M | 81% |
| Ingredients Segment | $5.7M | 17% |
| Other | $694.0K | 2% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
